Email Updates

You are here

MDP 301

Status
Completed
Phase
III
Principal Investigator(s)
Sheena McCormack, MBBS, MSc, FRCP
Objective

To determine the efficacy and safety of 0.5% and 2% PRO 2000/5 gels compared to placebo in preventing vaginally acquired HIV infection.

 

Last updated May 16, 2021

October 2005
September 2009
Date of Enrollment Completion
August 1, 2008
Enrollment
9 404
16
Years